GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » Beneish M-Score

HeraMED (ASX:HMD) Beneish M-Score : -4.20 (As of Mar. 26, 2025)


View and export this data going back to 2018. Start your Free Trial

What is HeraMED Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.2 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for HeraMED's Beneish M-Score or its related term are showing as below:

ASX:HMD' s Beneish M-Score Range Over the Past 10 Years
Min: -5.65   Med: -3.97   Max: 0.22
Current: -4.2

During the past 7 years, the highest Beneish M-Score of HeraMED was 0.22. The lowest was -5.65. And the median was -3.97.


HeraMED Beneish M-Score Historical Data

The historical data trend for HeraMED's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Beneish M-Score Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial 0.21 -5.54 -3.46 -3.96 -4.20

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.46 - -3.96 - -4.20

Competitive Comparison of HeraMED's Beneish M-Score

For the Medical Devices subindustry, HeraMED's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeraMED's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where HeraMED's Beneish M-Score falls into.


';

HeraMED Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of HeraMED for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5208+0.528 * 0.9984+0.404 * 0.4788+0.892 * 0.6159+0.115 * 1.2923
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.117+4.679 * -0.177074-0.327 * 0.5467
=-4.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was A$0.16 Mil.
Revenue was A$0.36 Mil.
Gross Profit was A$0.22 Mil.
Total Current Assets was A$3.71 Mil.
Total Assets was A$4.48 Mil.
Property, Plant and Equipment(Net PPE) was A$0.04 Mil.
Depreciation, Depletion and Amortization(DDA) was A$0.33 Mil.
Selling, General, & Admin. Expense(SGA) was A$2.86 Mil.
Total Current Liabilities was A$1.05 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.66 Mil.
Net Income was A$-5.49 Mil.
Gross Profit was A$0.12 Mil.
Cash Flow from Operations was A$-4.81 Mil.
Total Receivables was A$0.51 Mil.
Revenue was A$0.59 Mil.
Gross Profit was A$0.36 Mil.
Total Current Assets was A$1.93 Mil.
Total Assets was A$2.79 Mil.
Property, Plant and Equipment(Net PPE) was A$-0.09 Mil.
Depreciation, Depletion and Amortization(DDA) was A$0.65 Mil.
Selling, General, & Admin. Expense(SGA) was A$4.15 Mil.
Total Current Liabilities was A$1.95 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.162 / 0.364) / (0.505 / 0.591)
=0.445055 / 0.854484
=0.5208

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.355 / 0.591) / (0.219 / 0.364)
=0.600677 / 0.601648
=0.9984

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3.714 + 0.038) / 4.484) / (1 - (1.928 + -0.088) / 2.792)
=0.163247 / 0.340974
=0.4788

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.364 / 0.591
=0.6159

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.647 / (0.647 + -0.088)) / (0.326 / (0.326 + 0.038))
=1.157424 / 0.895604
=1.2923

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2.855 / 0.364) / (4.15 / 0.591)
=7.843407 / 7.021997
=1.117

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.659 + 1.054) / 4.484) / ((0 + 1.951) / 2.792)
=0.382025 / 0.698782
=0.5467

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-5.491 - 0.117 - -4.814) / 4.484
=-0.177074

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

HeraMED has a M-score of -4.14 suggests that the company is unlikely to be a manipulator.


HeraMED Beneish M-Score Related Terms

Thank you for viewing the detailed overview of HeraMED's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


HeraMED Business Description

Traded in Other Exchanges
N/A
Address
201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124
HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines